We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cutera Inc | NASDAQ:CUTR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.57 | 2.51 | 2.64 | 90 | 12:09:49 |
Only muscle sculpting system to treat up to eight areas simultaneously
Different treatment modes offer a personalized muscle treatment experience
CUTERA, INC., (Nasdaq: CUTR) ("Cutera" or the "Company") a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced today the U.S. limited commercial launch of truSculpt® flex, the Company’s new muscle sculpting platform. truSculpt flex is FDA-cleared for the improvement of abdominal tone, strengthening of the abdominal muscles, and development of a firmer abdomen. It is also cleared for the strengthening, toning, and firming of buttocks and thighs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005306/en/
truSculpt® flex by Cutera, redefining muscle sculpting technology. (Photo: Business Wire)
“We are proud to be the first aesthetics laser company to offer a muscle toning system that treats up to eight areas simultaneously, covering the largest treatment area in the body sculpting industry,” said Jason Richey, COO and Interim CEO of Cutera. “The truSculpt flex technology is further differentiated from other devices through its proprietary Multi-Directional Stimulation (MDS) technology that delivers three distinct treatment modes by replicating intensified crunch, squat and twisting actions. Furthermore, truSculpt flex extends our strong momentum in the $1 billion body sculpting market as the system’s muscle toning technology perfectly complements our truSculpt iD fat reduction technology. truSculpt flex is another significant step forward in shaping the future of aesthetics.”
Dr. Michael Somenek, Plastic Surgeon, Washington DC, a leading investigator for the truSculpt flex clinical studies, stated, “Cutera has done it again by partnering with leading physicians in the aesthetics industry to develop leading-edge technology. During the clinical study for truSculpt flex, our practice was very pleased with how the technology performed, and delivered, real, personalized muscle toning results for patients. This technology opens up the possibilities for any aesthetics provider looking to offer best-in-class muscle toning services.”
Research shows the market for fitness, mind and body services was $595B in 20171 with an increase of 14.5% in body shaping procedures year over year.2 Further, 60 million people are paying members at gyms and health clubs.3
About truSculpt flex
truSculpt flex is a muscle sculpting device that is clinically proven to strengthen, firm, and tone the abdomen, buttocks, and thighs.
Commercial shipments of truSculpt flex will begin immediately.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call +1 415-657- 5500 or 1-888-4CUTERA or visit cutera.com.
Sources:
View source version on businesswire.com: https://www.businesswire.com/news/home/20190626005306/en/
Matthew Scalo VP, Investor Relations & Corporate Development +1 415-657-5500 mscalo@cutera.com
Tanya Rodante Director of Marketing Communications +1 415-657-5500 trodante@cutera.com
1 Year Cutera Chart |
1 Month Cutera Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions